Ping An Healthcare and Technology Company Limited established a strategic partnership with Medtronic (MDT) Management Co., Ltd. at the 7th China International Import Expoeld at the National Exhibition and Convention Center (Shanghai) on 6 November, 2024. Leveraging their respective strengths, the two companies will collaborate extensively on cardiac health, chronic disease therapies, and medical clinical training to drive continuous improvement in healthcare service.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MDT:
- Raymond James says Edwards’ EARLY TAVR data also positive for Medtronic, Abbott
- Medtronic’s Affera ablation system granted FDA approval
- Johnson & Johnson reported strong earnings beat, says Barclays
- Medtronic price target raised to $93 from $90 at Truist
- Medtronic upgraded to Outperform from Sector Perform at RBC Capital
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
